The use of selective serotonin reuptake inhibitors(SSARIs) in the psychopharmacological approach to managing depressive and other related conditions, presents a huge moral problem for the corporate model of medicine and pharmaceutical usage .The Pharma industry are morally obliged to provide correct and updated information on the efficacy of these drugs I'm pumping on this child, there is a huge disconnect on information pertaining efficacy and side effect and the real importance of these drugs, personally I believe the drugs subjects the patient to more problem due to inherent suicidal tendencies of the drugs, with this in mind, it will present a conflict between my beliefs and ethical use of pharmaceuticals and hence will impact on the
